{
    "pmcid": "8748511",
    "qa_pairs": {
        "Against which SARS-CoV-2 variants has Fu2 shown efficacy without significant loss of potency?": [
            "Fu2 has shown efficacy against the beta and delta variants.",
            "Fu2 has shown efficacy against the alpha and gamma variants.",
            "Fu2 has shown efficacy against the lambda and mu variants.",
            "Fu2 has shown efficacy against the epsilon and kappa variants."
        ],
        "How does the nanobody Fu2 prevent the SARS-CoV-2 spike protein from binding to the ACE2 receptor?": [
            "Fu2 facilitates the dimerization of spike trimers, locking them in a non-functional state.",
            "Fu2 competes with ACE2 for binding to the spike protein, occupying the receptor site.",
            "Fu2 causes the spike protein to misfold, rendering it inactive.",
            "Fu2 cleaves the spike protein, preventing it from interacting with ACE2."
        ],
        "What potential therapeutic application does the study suggest for Fu2?": [
            "Fu2 could be used in combination with strategies to extend serum half-life, such as fusion with albumin-binding nanobodies.",
            "Fu2 could be administered as a nasal spray to prevent SARS-CoV-2 infection.",
            "Fu2 could be used as a vaccine adjuvant to enhance immune response.",
            "Fu2 could be delivered via nanoparticles for targeted lung delivery."
        ],
        "What role does the long CDR3 region of Fu2 play in its mechanism of action?": [
            "The long CDR3 region forms an interchain extension with the RBD's \u03b2-sheet, enhancing binding.",
            "The long CDR3 region directly blocks the ACE2 binding site on the RBD.",
            "The long CDR3 region stabilizes the spike protein in its 'down' conformation.",
            "The long CDR3 region interacts with the S2 subunit, preventing membrane fusion."
        ],
        "What unique ability does the bispecific monomeric nanobody Fu2 have in neutralizing SARS-CoV-2?": [
            "Fu2 binds simultaneously to two receptor-binding domains from different spike trimers, inducing spike trimer dimers.",
            "Fu2 binds to a single receptor-binding domain, preventing its conformational change.",
            "Fu2 binds to the ACE2 receptor directly, blocking viral entry.",
            "Fu2 induces the degradation of the spike protein through proteolytic pathways."
        ]
    }
}